These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 8419485)
1. IgA antibodies to a protective antigen in human Schistosomiasis mansoni. Grzych JM; Grezel D; Xu CB; Neyrinck JL; Capron M; Ouma JH; Butterworth AE; Capron A J Immunol; 1993 Jan; 150(2):527-35. PubMed ID: 8419485 [TBL] [Abstract][Full Text] [Related]
2. Sex-dependent neutralizing humoral response to Schistosoma mansoni 28GST antigen in infected human populations. Remoué F; Rogerie F; Gallissot MC; Guyatt HL; Neyrinck JL; Diakkhate MM; Niang M; Butterworth AE; Auriault C; Capron A; Riveau G J Infect Dis; 2000 May; 181(5):1855-9. PubMed ID: 10823801 [TBL] [Abstract][Full Text] [Related]
3. Intranasal administration of a Schistosoma mansoni glutathione S-transferase-cholera toxoid conjugate vaccine evokes antiparasitic and antipathological immunity in mice. Sun JB; Mielcarek N; Lakew M; Grzych JM; Capron A; Holmgren J; Czerkinsky C J Immunol; 1999 Jul; 163(2):1045-52. PubMed ID: 10395703 [TBL] [Abstract][Full Text] [Related]
4. Development of a vaccine strategy against human and bovine schistosomiasis. Background and update. Capron A; Riveau G; Grzych JM; Boulanger D; Capron M; Pierce R Trop Geogr Med; 1994; 46(4 Spec No):242-6. PubMed ID: 7825228 [TBL] [Abstract][Full Text] [Related]
5. Protective immunity induced in rat schistosomiasis by a single dose of the Sm28GST recombinant antigen: effector mechanisms involving IgE and IgA antibodies. Grezel D; Capron M; Grzych JM; Fontaine J; Lecocq JP; Capron A Eur J Immunol; 1993 Feb; 23(2):454-60. PubMed ID: 8436179 [TBL] [Abstract][Full Text] [Related]
6. Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection. Dunne DW; Butterworth AE; Fulford AJ; Kariuki HC; Langley JG; Ouma JH; Capron A; Pierce RJ; Sturrock RF Eur J Immunol; 1992 Jun; 22(6):1483-94. PubMed ID: 1601036 [TBL] [Abstract][Full Text] [Related]
7. Associations between specific antibody responses and resistance to reinfection in a Senegalese population recently exposed to Schistosoma mansoni. Vereecken K; Naus CW; Polman K; Scott JT; Diop M; Gryseels B; Kestens L Trop Med Int Health; 2007 Mar; 12(3):431-44. PubMed ID: 17313515 [TBL] [Abstract][Full Text] [Related]
8. Overproduction of SM28GST in a baculovirus expression vector and its use to evaluate the in vivo immune responses of mice vaccinated against Schistosoma mansoni with naked DNA encoding the SM28GST gene. Kayes SG; Shaneyfelt RC; Monteiro C; O'Brien JJ J Parasitol; 1998 Aug; 84(4):764-70. PubMed ID: 9714208 [TBL] [Abstract][Full Text] [Related]
9. Antibody responses to the fucosylated LacdiNAc glycan antigen in Schistosoma mansoni-infected mice and expression of the glycan among schistosomes. Nyame AK; Leppänen AM; Bogitsh BJ; Cummings RD Exp Parasitol; 2000 Dec; 96(4):202-12. PubMed ID: 11162373 [TBL] [Abstract][Full Text] [Related]
10. Neutralizing antibody responses elicited in mice immunized with recombinant bacillus Calmette-Guérin producing the Schistosoma mansoni glutathione S-transferase. Kremer L; Riveau G; Baulard A; Capron A; Locht C J Immunol; 1996 Jun; 156(11):4309-17. PubMed ID: 8666802 [TBL] [Abstract][Full Text] [Related]
11. Predominance of IgA deposits in glomeruli of Schistosoma mansoni infected mice. el-Sherif AK; Befus D Clin Exp Immunol; 1988 Jan; 71(1):39-44. PubMed ID: 3127090 [TBL] [Abstract][Full Text] [Related]
12. Induction of cytotoxic T-cell activity by the protective antigen of Schistosoma mansoni Sm28GST or its derived C-terminal lipopeptide. Pancré V; Gras-Masse H; Delanoye A; Herno J; Capron A; Auriault C Scand J Immunol; 1996 Nov; 44(5):485-92. PubMed ID: 8947600 [TBL] [Abstract][Full Text] [Related]
13. Expression of a Schistosoma mansoni 28-kilodalton glutathione S-transferase in the livers of transgenic mice and its effect on parasite infection. Xu X; Lemaire C; Grzych JM; Pierce RJ; Raccurt M; Mullier F; Zerimech F; Decavel JP; Peyrol S; Liu J; Fontaine J; Lafitte S; Capron A; Cesbron JY Infect Immun; 1997 Sep; 65(9):3867-74. PubMed ID: 9284165 [TBL] [Abstract][Full Text] [Related]
14. Identification of the immunodominant T cell epitope of p38, a major egg antigen, and characterization of the epitope-specific Th responsiveness during murine schistosomiasis mansoni. Chen Y; Boros DL J Immunol; 1998 Jun; 160(11):5420-7. PubMed ID: 9605143 [TBL] [Abstract][Full Text] [Related]
15. Cluster analysis of schistosome-specific antibody responses partitions the population into distinct epidemiological groups. Mutapi F; Mduluza T; Roddam AW Immunol Lett; 2005 Jan; 96(2):231-40. PubMed ID: 15585328 [TBL] [Abstract][Full Text] [Related]
16. Schistosoma mansoni ex vivo lung-stage larvae excretory-secretory antigens as vaccine candidates against schistosomiasis. El Ridi R; Tallima H Vaccine; 2009 Jan; 27(5):666-73. PubMed ID: 19056448 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and bioactivities of two multiple antigen peptides as potential vaccine against schistosoma. Huang HQ; Li SC; Qin ZH; Cao SL; Yao Y; Liu YS; Li HY; Cai MS; Li ZJ; Shi YE Bioorg Med Chem Lett; 2005 May; 15(9):2415-9. PubMed ID: 15837336 [TBL] [Abstract][Full Text] [Related]
18. Schistosoma mansoni: the host immune response to egg antigens. I. Partial characterization of cellular and humoral responses to pI fractions of soluble egg antigens. Harn DA; Danko K; Quinn JJ; Stadecker MJ J Immunol; 1989 Mar; 142(6):2061-6. PubMed ID: 2493503 [TBL] [Abstract][Full Text] [Related]
19. Specific isotype immune response in the diagnosis of human schistosomiasis pathology? Bonnard P; Remoue F; Schacht AM; Deuffic-Burban S; Dompnier JP; Elguero E; Charrier N; Cassagnou M; Diop M; Ly A; Capron A; Riveau G Am J Trop Med Hyg; 2004 Aug; 71(2):202-5. PubMed ID: 15306711 [TBL] [Abstract][Full Text] [Related]